SBI Securities’s Checkpoint Therapeutics CKPT Stock Holding History

SBI Securities’s Portfolio CKPT Stock Details CKPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-123	Closed	-$497	–	4158
2025 Q1	$497	Sell	123 -9,958	-99%	-$33.2K	﹤0.01%	2878
2024 Q4	$32.3K	Buy	+10,081	New	+$34.2K	﹤0.01%	1134

SBI Securities's CKPT Position: Q2 2025 in Review

SBI Securities sold out of Checkpoint Therapeutics (CKPT) in Q2 2025, closing a stake of 123 shares — an estimated $497 sold.

SBI Securities first reported a position in CKPT in Q4 2024 and held it in 2 quarters. The position peaked at $32.3K in Q4 2024. 0 funds tracked by Wall St. Rank hold CKPT as of Q2 2025.

SBI Securities reported no remaining Checkpoint Therapeutics position as of Q2 2025 after selling out during the quarter.
SBI Securities sold 123 Checkpoint Therapeutics shares in Q2 2025, an estimated $497.
SBI Securities first reported a position in Checkpoint Therapeutics in Q4 2024 and held it in 2 quarters.
SBI Securities's Checkpoint Therapeutics position peaked at $32.3K in Q4 2024.
0 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2025.

Based on SBI Securities's 13F filing for Q2 2025, filed 8 Aug 2025.